Cash Flow Statement
Growth Metrics

AdaptHealth (AHCO) Divestments (2025)

AdaptHealth's quarterly Divestments came in at $3.2 million in Q4 2025, up 116.19% quarter-over-quarter from $1.5 million in Q3 2025.

AdaptHealth has reported Divestments for 1 years, with the latest figure at $3.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Divestments changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $4.7 million (changed N/A YoY), and the FY2025 full-year result was $120.4 million, changed N/A from the prior year.
  • Divestments for Q4 2025 stood at $3.2 million, up from $1.5 million in the prior quarter.
  • The five-year high for Divestments was $3.2 million in Q4 2025, with the low at $1.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 AdaptHealth 1.35 Bn 1.31 Bn 111.50 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.25 Mn
Sep 30, 2025 1.50 Mn